166 related articles for article (PubMed ID: 16489258)
1. The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformis.
Zebrowska A; Narbutt J; Sysa-Jedrzejowska A; Kobos J; Waszczykowska E
Mediators Inflamm; 2005 Dec; 2005(6):373-9. PubMed ID: 16489258
[TBL] [Abstract][Full Text] [Related]
2. Disturbances of the expression of metalloproteinases and their tissue inhibitors cause destruction of the basement membrane in pemphigoid.
Narbutt J; Waszczykowska E; Lukamowicz J; Sysa-Jedrzejowska A; Kobos J; Zebrowska A
Pol J Pathol; 2006; 57(2):71-6. PubMed ID: 17019968
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
Papakonstantinou E; Dionyssopoulos A; Aletras AJ; Pesintzaki C; Minas A; Karakiulakis G
J Am Acad Dermatol; 2004 Oct; 51(4):526-33. PubMed ID: 15389186
[TBL] [Abstract][Full Text] [Related]
4. Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis.
Montagnana M; Volpe A; Lippi G; Caramaschi P; Salvagno GL; Biasi D; Bambara LM; Guidi GC
Clin Biochem; 2007 Aug; 40(12):837-42. PubMed ID: 17493602
[TBL] [Abstract][Full Text] [Related]
5. Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection.
Ishii T; Asuwa N
Hum Pathol; 2000 Jun; 31(6):640-6. PubMed ID: 10872655
[TBL] [Abstract][Full Text] [Related]
6. Altered matrix metalloproteinases and tissue inhibitors of metalloproteinases in embryos from diabetic rats during early organogenesis.
Higa R; Kurtz M; Capobianco E; Martínez N; White V; Jawerbaum A
Reprod Toxicol; 2011 Dec; 32(4):449-62. PubMed ID: 21963884
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid.
Niimi Y; Pawankar R; Kawana S
Int Arch Allergy Immunol; 2006; 139(2):104-13. PubMed ID: 16374020
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
9. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in tuberculous pleuritis].
Hoheisel G; Sack U; Hui DS; Lai F; Chan KS; Choi CH; Schauer J; Tannapfel A
Pneumologie; 2004 May; 58(5):305-8. PubMed ID: 15162254
[TBL] [Abstract][Full Text] [Related]
13. Metalloproteinases and Their Inhibitors in Patients with Inguinal Hernia.
Isik A; Gursul C; Peker K; Aydın M; Fırat D; Yılmaz İ
World J Surg; 2017 May; 41(5):1259-1266. PubMed ID: 28050662
[TBL] [Abstract][Full Text] [Related]
14. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients.
Lobmann R; Ambrosch A; Schultz G; Waldmann K; Schiweck S; Lehnert H
Diabetologia; 2002 Jul; 45(7):1011-6. PubMed ID: 12136400
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin C, matrix metalloproteinases, and their tissue inhibitors in gingiva and gingival crevicular fluid from periodontitis-affected patients.
Soell M; Elkaim R; Tenenbaum H
J Dent Res; 2002 Mar; 81(3):174-8. PubMed ID: 11876270
[TBL] [Abstract][Full Text] [Related]
19. Purified human chondroitin-4-sulfate reduced MMP/TIMP imbalance induced by iron plus ascorbate in human fibroblast cultures.
Campo GM; Avenoso A; Campo S; D'Ascola A; Ferlazzo AM; Samà D; Calatroni A
Cell Biol Int; 2006 Jan; 30(1):21-30. PubMed ID: 16275145
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of matrix metalloproteinases and tissue-derived inhibitors of metalloproteinase in fetal and adult skins.
Chen W; Fu X; Ge S; Sun T; Sheng Z
Int J Biochem Cell Biol; 2007; 39(5):997-1005. PubMed ID: 17409012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
